Associated partners

Faculdade de Ciências Da Universidade de Lisboa

ULisboa is responsible for making the city of Lisbon one of the great European capitals of culture and science, as it welcomes more than 9000 foreign students every year – about 17,8% of the total number of students – from over 100 countries, who are seeking high quality education as well as a different culture, delightful weather and the hospitality that Lisbon, and Portugal, have to offer.

ULisboa is currently Portugal’s largest University and one of Europe’s largest. Located in the heart of the city, it provides its entire community with the best and most diverse academic programs and vows to deliver a uniquely enriching experience.

Lubeck University

Research and teaching at the Universität zu Lübeck started in the field of medicine, but our informatics, natural sciences, and engineering sections today encompass much more. The common element among them is their emphasis on life science, also mirrored by our motto:
Im Focus das Leben.

The ubiquitous, intensive, interdisciplinary exchange at the university is the motor behind our superior, internationally outstanding, innovative and knowledge-oriented basic research marked by multifaceted applications. We strive to constantly raise the bar for the quality of our research and education and to master the challenges and opportunities in a worldwide competition. We thus team-up with both national and international research institutions.

Centro Hospitalar Universitário de Lisboa Central

missing

National and Kapodistrian University of Athens, Medical School

The Medical School, National and Kapodistrian University of Athens (NKUA), Greece is staffed by clinical and academic researchers working across the University and at University Hospitals in Athens. The expertise within the University spans a full range from molecular techniques through clinical research and clinical trials. State-of-the-art research facilities such animal facility unit, molecular biology, gene transfer/therapy and many other modern molecular technologies are available. Clinical studies are focused among others on the molecular mechanisms of kidney disease, cardiovascular diseases and carcinogenesis.

Universitätsklinikum RWTH Aachen

Universitätsklinikum Aachen (UKA1) is constituted by the Institute for Molecular Cardiovascular Research (IMCAR), a research institute localized inside the University Hospital of Aachen. UKA1 is dedicated to pursuing scientific excellence in the field of cardiovascular biology with special focus on chronic renal failure, vascular remodelling and cardiovascular disease. UKA1 has built his expertise on transgenic mouse models of disease to study cardiovascular disease and vascular remodelling in an in vivo context, as well as on molecular and cellular biology to unravel associated pathological pathways. In addition, IMCAR has extensive expertise in mass spectrometry and chromatography aiming at the identification of novel prognostic factors for cardiovascular risk assessment and the identification and characterization of novel pharmaceutical targets.

Servizio Andaluz de Salud (University Hospital Reina Sofia)

The mission of the Reina Sofía University Hospital is to improve the health level of its reference population by providing highly specialized and quality healthcare through the authorized portfolio of services. The Hospital will ensure continuity of care through the necessary coordination with Primary Care. It will ensure that the provision of services meets the needs and expectations of citizens by incorporating techniques, procedures and innovations that ensure a constantly updated and cutting-edge portfolio, as befits a third-level hospital.

As a university hospital, the center's mission is to contribute to the training of undergraduate students in related disciplines: currently Medicine, Nursing and Physiotherapy. The Hospital's mission is also to train specialist physicians in different areas of knowledge.

Together with the Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), the hospital has among its goals the promotion of innovation and quality research in areas related to health.

The PROMOTE project has received funding from the European Union’s Horizon Europe Marie Skłodowska-Curie Actions Doctoral Networks - Industrial Doctorates Programme (HORIZON-MSCA-2023-DN-01) under grant agreement No 101169245.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.